Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 HKD | -2.85% | -3.60% | -15.16% |
Apr. 30 | Chaoju Eye Care Unit Buys Structured Deposits Worth 150 Million Yuan | MT |
Apr. 16 | Chaoju Eye Care Arms Ink Five Tenancy Deals in Inner Mongolia | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 65% by 2026.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company returns high margins, thereby supporting business profitability.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.16% | 323M | - | ||
-22.44% | 15.75B | B+ | ||
+3.60% | 12.47B | B | ||
+3.98% | 11.73B | B+ | ||
+3.69% | 10.24B | B+ | ||
+26.63% | 8.51B | B | ||
-7.49% | 7.38B | A- | ||
+7.08% | 6.78B | B- | ||
+2.86% | 6.25B | D | ||
-4.31% | 4.33B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2219 Stock
- Ratings Chaoju Eye Care Holdings Limited